Fifty Japanese patients with insulin-dependent diabetes mellitus (IDDM) and 94 normal subjects were genotyped for Bg/II restriction-fragment-length polymorphism (RFLP) of the T-lymphocyte-receptor β-chain (TLRβ)-region gene and analyzed in relation to HLA-DR phenotypes. The antigen frequencies of DR4 and DR9 in the IDDM population were significantly higher than those in the normal population, with relative risks of 1.87 (P < .02) and 2.42 (P < .01), respectively. Hybridization of digested DNA with the TLRβ probe revealed two alleles of 9.3 and 8.6 kilobases (kb). The allele frequency of 8.6 kb in patients with IDDM (79%) was significantly (P < .05) higher than that in normal subjects (64%). When TLRβ-region RFLP in IDDM was further analyzed with respect to the HLA-DR phenotypes, the frequency of 8.6 kb was significantly increased in patients with DR4 but not DR9 (DR4/X) and those with DR9 but not DR4 (DR9/X) compared with the frequency found in normal subjects (P < .05); the relative risks of 8.6 kb in DR4/X and DR9/X were 2.77 and 4.98, respectively. Although the frequencies of HLA-DR phenotypes and of TLRβ-region RFLP in IDDM and normal subjects were apparently different from those reported for Caucasians, this population-association study indicates that in the Japanese, genes conferring susceptibility to IDDM exist near or at the HLA-DR and the TLRβ loci, as has been demonstrated in Caucasians.
Skip Nav Destination
Article navigation
Original Articles|
December 01 1988
Association of HLA-DR Phenotypes and T-Lymphocyte–Receptor β-Chain–Region RFLP With IDDM in Japanese
Masafumi Ito;
Masafumi Ito
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Mitsune Tanimoto;
Mitsune Tanimoto
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Hiromi Kamura;
Hiromi Kamura
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Masahiro Yoneda;
Masahiro Yoneda
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Yasuo Morishima;
Yasuo Morishima
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Kensuke Takatsuki;
Kensuke Takatsuki
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Takeharu Itatsu;
Takeharu Itatsu
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Hidehiko Saito
Hidehiko Saito
Department of Internal Medicine, Nagoya University School of Medicine; the Histocompatibility Laboratory
Department of Endocrinology and Metabolism, Nagoya Second Red Cross Hospital; and the Aichi Red Cross Blood Center
Nagoya, Japan
Search for other works by this author on:
Address correspondence and reprint requests to Masafumi Ito, MD, First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466, Japan.
Diabetes 1988;37(12):1633–1636
Article history
Received:
February 17 1988
Revision Received:
June 08 1988
Accepted:
June 08 1988
PubMed:
2903835
Citation
Masafumi Ito, Mitsune Tanimoto, Hiromi Kamura, Masahiro Yoneda, Yasuo Morishima, Kensuke Takatsuki, Takeharu Itatsu, Hidehiko Saito; Association of HLA-DR Phenotypes and T-Lymphocyte–Receptor β-Chain–Region RFLP With IDDM in Japanese. Diabetes 1 December 1988; 37 (12): 1633–1636. https://doi.org/10.2337/diab.37.12.1633
Download citation file:
45
Views